Related Experiment Videos
Serum CPK isoenzymes after cardiac catheterization
British Heart Journal
|November 1, 1975
Summary
Measuring MB CPK isoenzyme reliably indicates myocardial infarction in patients undergoing cardiac catheterization. This cardiac biomarker is unaffected by non-cardiac enzyme release during the procedure, unlike total CPK.
Area of Science:
- Cardiology
- Biochemistry
- Diagnostic Medicine
Background:
- Preoperative exclusion of acute myocardial infarction is crucial for successful coronary revascularization.
- Conventional serum enzymes (AST, LDH, total CPK) can be falsely elevated post-cardiac catheterization due to non-cardiac sources.
- MB CPK isoenzyme, primarily found in heart muscle, offers greater specificity for cardiac injury.
Purpose of the Study:
- To evaluate the reliability of MB CPK isoenzyme activity in diagnosing myocardial infarction.
- To compare MB CPK levels with total CPK in patients undergoing cardiac catheterization.
Main Methods:
- Serum total CPK and MB CPK activities were measured in 53 patients before and 24 hours after cardiac catheterization.
- MB CPK levels were also assessed in 50 patients with confirmed acute myocardial infarction and 20 healthy controls.
- Procedures included selective coronary arteriography via brachial or femoral artery approaches.
Main Results:
- Patients with acute myocardial infarction showed significantly elevated total CPK and MB CPK levels.
- Control subjects without cardiovascular disease had normal MB CPK activity (<0.004 IU/ml).
- Patients undergoing catheterization had elevated total CPK but normal MB CPK levels, indicating no myocardial infarction.
Conclusions:
- Elevated MB CPK isoenzyme activity is a specific and reliable indicator of myocardial infarction.
- MB CPK is a superior biomarker compared to total CPK for diagnosing myocardial infarction in patients who have undergone cardiac catheterization.
- This finding aids in accurate preoperative assessment and management of patients undergoing coronary revascularization.